Rep. Waxman Requests GAO Report On Part D "Windfall" To Drug Manufacturers
This article was originally published in The Pink Sheet Daily
Executive Summary
The representative is asking GAO to determine by how much drug prices paid by Medicare Part D prescription drug plans differ from Medicaid payments.